Literature DB >> 8057429

Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice.

L G Guidotti1, V Martinez, Y T Loh, C E Rogler, F V Chisari.   

Abstract

Transgenic mice that express the hepatitis B virus core protein were used to examine factors that influence the intracellular localization of nucleocapsid particles in the primary hepatocyte in vivo. In this model, viral nucleocapsid particles are strictly localized to the nucleus of the hepatocyte except when the nuclear membrane dissolves during cell division, at which time they enter the cytoplasm. The cytoplasmic nucleocapsid particles do not reenter the nucleus, however, when the nuclear membrane re-forms after cell division. The data support the notion that nucleocapsid particles can form de novo within the nucleus, and they suggest that performed nucleocapsid particles cannot be transported across the intact nuclear membrane in either direction. The results imply that nucleocapsid disassembly is probably required for entry of the hepadnaviral genome into the nucleus, and they question the role of the intranuclear viral nucleocapsid particle during the viral life cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057429      PMCID: PMC236947     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells.

Authors:  M A Petit; J Pillot
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.

Authors:  F V Chisari; P Filippi; A McLachlan; D R Milich; M Riggs; S Lee; R D Palmiter; C A Pinkert; R L Brinster
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.

Authors:  A McLachlan; D R Milich; A K Raney; M G Riggs; J L Hughes; J Sorge; F V Chisari
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

4.  Developmentally regulated mRNAs in mouse liver.

Authors:  R K Barth; K W Gross; L C Gremke; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Crystalline aggregates of hepatitis B core particles in cytoplasm of hepatocytes.

Authors:  T Michalak; A Nowosławski
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

6.  Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.

Authors:  S Stahl; P MacKay; M Magazin; S A Bruce; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Hepatitis-associated antigen hepatitis. An electron microscopic study of virus-like particles in liver cells.

Authors:  S Huang
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

8.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors:  C M Chu; Y F Liaw
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

9.  Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways.

Authors:  L G Guidotti; S Guilhot; F V Chisari
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

View more
  42 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

3.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

4.  In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Authors:  Xiaonan Zhang; Wei Lu; Ye Zheng; Weixia Wang; Lu Bai; Liang Chen; Yanling Feng; Zhanqing Zhang; Zhenghong Yuan
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

5.  Characterization of nuclear localization of a hepatitis B virus precore protein derivative P22.

Authors:  C T Yeh; L H Hong; J H Ou; C M Chu; Y F Liaw
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  In vitro model for the nuclear transport of the hepadnavirus genome.

Authors:  M Kann; A Bischof; W H Gerlich
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 7.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

8.  Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Authors:  I Fourel; J M Cullen; J Saputelli; C E Aldrich; P Schaffer; D R Averett; J Pugh; W S Mason
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 9.  Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

10.  Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids.

Authors:  Birgit Rabe; Mildred Delaleau; Andreas Bischof; Michael Foss; Irina Sominskaya; Paul Pumpens; Christian Cazenave; Michel Castroviejo; Michael Kann
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.